Similar articles

• A randomized controlled trial of interim methadone maintenance.

  Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ. Schwartz RP, et al. Arch Gen Psychiatry. 2006 Jan;63(1):102-9. doi: 10.1001/archpsyc.63.1.102. Arch Gen Psychiatry. 2006. PMID: 16389204 Clinical Trial.
• Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.

  Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM. Banta-Green CJ, et al. Addiction. 2009 May;104(5):775-83. doi: 10.1111/j.1360-0443.2009.02538.x. Epub 2009 Mar 13. Addiction. 2009. PMID: 19344438
• Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.

  Madden A, Lea T, Bath N, Winstock AR. Madden A, et al. Drug Alcohol Rev. 2008 Nov;27(6):671-8. doi: 10.1080/09595230801935706. Drug Alcohol Rev. 2008. PMID: 19378450
• Biological correlates of methadone maintenance pharmacotherapy.

  Kreek MJ. Kreek MJ. Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:9-14. Ann Med Interne (Paris). 1994. PMID: 7880038 Review. No abstract available.
• Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.

  Farnia M, Ebrahimi B, Shams A, Zamani S. Farnia M, et al. Int J Drug Policy. 2010 Sep;21(5):422-4. doi: 10.1016/j.drugpo.2010.03.008. Epub 2010 Apr 21. Int J Drug Policy. 2010. PMID: 20413287 Review.